BioAge Labs
The AI engine Fit Assessment
BetaBioAge is a biotechnology company focused on discovering and developing therapeutics to address aging and related diseases. Their mission is to extend healthy lifespan by targeting the molecular causes of aging through a diverse portfolio of drugs.
Blurb
BioAge Labs is a clinical-stage biotechnology company that develops therapeutics to treat obesity and metabolic diseases.
HQ Location
Richmond (United States)
Founded
2015
Employees
85
Total funding raised
$293.90M
Last Funding Event
IPO, $615.01M, September 26, 2024
Smart insights
- 6m headcount growth: 10%
- 1Y headcount growth: 12%
- Headcount-to-last-round ratio: 4.0 employees/$M
Operator of a biotechnology company designed to harness the biology of human aging to create therapies for metabolic diseases. The company offers a proprietary platform with extensive molecular measurements that identify novel biological insights and druggable mechanisms, enabling clients with targeted treatments for age-related diseases.